Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shijun Yan

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Veterinary Science|February 11, 2022
Construction and Immunogenicity of a Recombinant Pseudorabies Virus Variant With TK/gI/gE/11k/28k DeletionShijun Yan, Baicheng Huang, Xiaofei Bai, et al.
Technology in Cancer Research & Treatment|July 4, 2013
Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapyYunzhou Wu, Shijun Yan, Zheng Lv, et al.
Journal of Medicinal Chemistry|October 7, 2017
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's DiseaseJole Fiorito, Jeremie Vendome, Faisal Saeed, et al.
Nutrition & Diabetes|October 16, 2019
Gpr17 deficiency in POMC neurons ameliorates the metabolic derangements caused by long-term high-fat diet feedingAustin M Reilly, Shudi Zhou, Sunil K Panigrahi, et al.
Parkinsonism & Related Disorders|January 9, 2026
Compartment-specific correlation of pathological α-synuclein in prodromal Parkinson's diseaseSinah Röttgen, Michael Sommerauer, Shijun Yan, et al.
Brain : a Journal of Neurology|October 28, 2017
PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's diseaseFang Du, Qing Yu, Shijun Yan, et al.
Journal of Pharmacological Sciences|May 14, 2016
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapyYunzhou Wu, Jinjiao He, Ying An, et al.
Diabetes|August 25, 2016
F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive DeclineShijun Yan, Fang Du, Long Wu, et al.
JAMA Neurology|December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson DiseaseShijun Yan, Cheng Jiang, Annette Janzen, et al.
Journal of Medical Virology|August 12, 2020
The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice modelJinjiao He, Ying An, Jianying Qi, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Veterinary Science|February 11, 2022
Construction and Immunogenicity of a Recombinant Pseudorabies Virus Variant With TK/gI/gE/11k/28k DeletionShijun Yan, Baicheng Huang, Xiaofei Bai, et al.
Technology in Cancer Research & Treatment|July 4, 2013
Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapyYunzhou Wu, Shijun Yan, Zheng Lv, et al.
Journal of Medicinal Chemistry|October 7, 2017
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's DiseaseJole Fiorito, Jeremie Vendome, Faisal Saeed, et al.
Nutrition & Diabetes|October 16, 2019
Gpr17 deficiency in POMC neurons ameliorates the metabolic derangements caused by long-term high-fat diet feedingAustin M Reilly, Shudi Zhou, Sunil K Panigrahi, et al.
Parkinsonism & Related Disorders|January 9, 2026
Compartment-specific correlation of pathological α-synuclein in prodromal Parkinson's diseaseSinah Röttgen, Michael Sommerauer, Shijun Yan, et al.
Brain : a Journal of Neurology|October 28, 2017
PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's diseaseFang Du, Qing Yu, Shijun Yan, et al.
Journal of Pharmacological Sciences|May 14, 2016
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapyYunzhou Wu, Jinjiao He, Ying An, et al.
Diabetes|August 25, 2016
F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive DeclineShijun Yan, Fang Du, Long Wu, et al.
JAMA Neurology|December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson DiseaseShijun Yan, Cheng Jiang, Annette Janzen, et al.
Journal of Medical Virology|August 12, 2020
The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice modelJinjiao He, Ying An, Jianying Qi, et al.
Pageof 7